IRCT20200105046010N70招募中未知
In- Vivo Bioequivalence study of Metformin ER tablets1000 mg Kooshan Pharmed Co. (Gly-Once® 1000 mg ER Tablet) with brand drugs (Glucophage® 1000 mg ER Tablet ,Merck Sharp & Dohme, Germany ) in Iranian healthy volunteers.
Koushan Pharmed Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-55 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the dru
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Metformin 500mg tablet (Zagross Darou Pharma)IRCT20200105046010N36Zagross Darou Pharmaceutical Company24
招募中
不适用
Bioequivalence study of Metformin ER 500 mg tabletIRCT20220111053692N3Saponine Pharmaceutical Company24
招募中
Unknown
In vivo Bioequivalence study of Metformin sustained release tabletIRCT20220211053992N18Tabriz University of Medical Sciences24
尚未招募
Unknown
In-vivo Bioequivalence Study of Metformin 500 mg FC. Tablets of The Test Drug ( Sajjad Darou, Iran)IRCT20200105046010N106Sajad darou shargh24
尚未招募
Unknown
Bioequivalence evaluation of Metformin Tablet 1000 mg of Mahban Pharmaceutical companyIRCT20200625047913N13Hezareh Sevom Futuristic Pharmacist24